Subscribe: Google Podcasts | Spotify | Stitcher | RSS | More
In this short extra episode, Jim talks to Robin Hanson about possible dosage related effects on exposure and the related trade-offs of viral dose & deliberate infection strategies, the need for more investment in robustness, capacity vs flexibility, optimizing for adaptability, our lack of leadership, and more.
Robin Hanson is an Associate Professor of Economics, and received his Ph.D in 1997 in social sciences from Caltech. He joined George Mason’s economics faculty in 1999 after completing a two-year post-doc at U.C Berkely. His major fields of interest include health policy, regulation, and formal political theory.